![Willard Dere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Willard Dere
Président chez
METAGENOMI THERAPEUTICS, INC.
Fortune : 3 M $ au 31/05/2026
Profil
Willard H.
Dere is currently Chairman at Metagenomi Therapeutics, Inc. since 2025, Independent Director at BioMarin Pharmaceutical, Inc. since 2016, Independent Director at Seres Therapeutics, Inc. since 2017, Director at Peel Therapeutics, Inc., and Chief Medical Officer at Angitia Biopharmaceuticals Guangzhou Ltd. since 2023.
Former positions include Independent Director at Radius Health, Inc. from 2014 to 2022, Independent Director at OCERA Therapeutics LLC from 2016 to 2017, Independent Director at Mersana Therapeutics, Inc. from 2018 to 2026, Professor & Executive Director-Personalized Health at The University of Utah Health Sciences Center from 2014 to 2022, Director at Metagenomi Technologies LLC, Vice President-Endocrine & Bone at Eli Lilly & Co. from 1989 to 2003, Associate Vice President-Research at Clinical & Translational Science Institute, Associate Professor at The Indiana University School of Medicine from 1999 to 2009, Principal at Center for Genomic Medicine Massachusetts General Hospital, and International Chief Medical Officer at Amgen, Inc. from 2007 to 2014.
Education includes undergraduate and doctorate degrees from the University of California, Davis, conferred in 1977 and 1980 respectively.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/06/2026 | 46 440 ( 0,02 % ) | 3 M $ | 31/05/2026 | |
| 09/06/2026 | 51 275 ( 0,14 % ) | 69 734 $ | 31/05/2026 | |
SERES THERAPEUTICS INC 0,02 % | 13/04/2026 | 1 587 ( 0,02 % ) | 11 617 $ | 31/05/2026 |
| 06/01/2026 | 0 ( -.--% ) | - $ | 31/12/2025 |
Postes actifs de Willard Dere
| Sociétés | Poste | Début |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 18/07/2016 |
| SERES THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/07/2017 |
| METAGENOMI THERAPEUTICS, INC. | Président | 11/11/2025 |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Angitia Biopharmaceuticals Guangzhou Ltd.
 Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Directeur Technique/Scientifique/R&D | 01/06/2023 |
Anciens postes connus de Willard Dere
| Sociétés | Poste | Fin |
|---|---|---|
| MERSANA THERAPEUTICS | Directeur/Membre du Conseil | 06/01/2026 |
| RADIUS HEALTH, INC. | Directeur/Membre du Conseil | 15/08/2022 |
| OCERA THERAPEUTICS INC | Directeur/Membre du Conseil | 11/12/2017 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/10/2014 |
| ░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Willard Dere
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Utah Health Sciences Center | |
Clinical & Translational Science Institute
 Clinical & Translational Science Institute Engineering & ConstructionIndustrial Services Provides infrastructure services | Industrial Services |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Angitia Biopharmaceuticals Guangzhou Ltd.
Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Center for Genomic Medicine Massachusetts General Hospital |
